Use of plasma exchange and heparin during cardiopulmonary bypass for a patient with heparin induced thrombocytopenia: A case report

Journal of Cardiac Surgery

Volumn 16, Issue 4, 2001, Pages 313-318

  Kajitani, Michio ^a   Aguinaga, Miguel ^a   Johnson, Charles E ^a   Scott, Margie A ^a   Antakli, Tamim ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANCROD; ARGATROBAN; CLOPIDOGREL; DANAPAROID; DERMATAN SULFATE; ECARIN; HEPARIN; HEPARIN DERIVATIVE; ILOPROST; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PORCINE INTESTINAL HEPARIN; PROTAMINE SULFATE; RECOMBINANT HIRUDIN; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CONVALESCENCE; CORONARY ARTERY DISEASE; DRUG APPROVAL; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG SAFETY; HEPARINIZATION; HUMAN; MALE; PLASMAPHERESIS; PREOPERATIVE CARE; SURGICAL RISK; THROMBOCYTOPENIA; UNITED STATES;

ACUTE DISEASE; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; CORONARY DISEASE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; SYNDROME; THROMBOCYTOPENIA; UNITED STATES;

EID: 0035707287     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb00527.x     Document Type: Article

References (39)

1. Heparin-induced thrombocytopenia and thrombosis
2. Anticoagulants and extracorporeal circuits
3. Thrombocytopenia occurring during administration of heparin: A prospective study of 52 patients
4. Heparin-associated thrombocytopenia
5. Studies on the frequency of heparin-associated thrombocytopenia
6. Heparin-associated thrombocytopenia
7. Heparin-induced thrombocytopenia
8. Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and immunologic type are closely linked in their pathogenesis
9. Fatal effect of reexposure to heparin after previous heparin-associated thrombocytopenia and thrombosis
10. Heparin-induced thrombocytopenia: Laboratory investigation and confirmation of diagnosis
11. Heparin-associated thrombocytopenia: The antibody is not heparin specific
12. Heparin-induced thrombocytopenia
13. Heparinoid anticoagulation with topical human fibrin sealant during cardiac surgery in a patient with heparin-induced thrombocytopenia
14. Clinical effect of concurrent warfarin therapy on the efficacy of argatroban therapy in heparin-induced thrombocytopenia
15. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and the heparin-induced thrombocytopenia and thrombosis syndrome
16. Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome
17. Heparin-less cardiopulmonary bypass revisited: A newer strategy to avoid heparin-related bleeding using dermatan sulfate
18. Is heparin the ideal anticoagulant for cardiopulmonary bypass: Dermatan sulphate may be an alternate choice
19. Clinical experience with a new antithrombotic (dermatan sulfate) in chronic hemodialysis patients
20. Antithrombotic properties of dermatan suphate (MF 701) in haemodialysis for chronic renal failure
21. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis
22. Management of cardiopulmonary bypass and associated problems
23. Intraoperative management of patients with heparin-induced thrombocytopenia
24. Recombinant hirudin in the treatment of heparin-induced thrombocytopenia (HIT) type II
25. Recombinant hirudin (Lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study
26. Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in man
27. Recombinant hirudin as anticoagulant in cardiac surgery: Experiences with eleven patients
28. Recombinant hirudin as anticoagulant during open heart surgery
29. Monitoring of r-hirudin anticoagulation during acriopulmonary bypass: Assessment of the whole blood ecarin clotting time
30. Treatment of serious heparin-induced thrombocytopenia by plasma exchange: Report on four cases
31. Plasmaphresis in the management of heparin-associated thrombocytopenia with thrombosis
32. Plasmaphresis: A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis
33. Diagnostic and therapeutic strategies of white clot syndrome
34. Heparin-induced thrombocytopenia: Further studies of the effects of heparin-dependent antibodies on platelets
35. Heparin-associated thrombocytopenia: A comparison of three heparin preparations
36. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery
37. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive to heparin: Platelet factor 4 complexes
38. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolucular PF4-heparin complex as the major antigen
39. High incidence of antiheparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery